CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down- regulation by CD8+ T cells

Clinical and Experimental Immunology

Volumn 112, Issue 2, 1998, Pages 216-225

  Palmen, M J H J ^a,b   Wijburg, O L C ^a   Kunst, I H ^a   Kroes, H ^a   Van Rees, E P ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

CD4+T cells; Colitis; Migration; Transfer

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CELL MIGRATION; CELL TRANSFER; COLITIS; DOWN REGULATION; GENE TRANSLOCATION; HELPER CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; SUPPRESSOR CELL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; COLON; DINITROFLUOROBENZENE; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-2; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; RATS; TRINITROBENZENESULFONIC ACID;

EID: 0031752072     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00564.x     Document Type: Article

References (54)

1. Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L. Expression of class II molecules on intestinal epithelial cells in humans. Gastroenterol 1941; 100:3-12.
2. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1943; 75:253-61.
3. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995; 25:2618-25.
4. + T cells induce or protect from chronic intestinal inflammation in C.B-17 SCID mice. Int Immunol 1993; 5:1461-71.
5. Stronkhorst A, Tytgat NJ, Van Deventer JH. CD4 antibody treatment in Crohn's disease. Scand J Gastroenterol 1992; 194:61-65.
6. Deusch K, Mauthe B, Reiter C, Riethmuller G, Classen M. CD4-antibody treatment of inflammatory bowel disease: one-year follow up. Gastroenterol 1993; 104:A691.
7. van Kruiningen HJ. On the use of antibiotics in Crohn's disease. J Clin Gastroenterol 1995; 20:310-6.
8. Videla S, Vilaseca J, Guarner F et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 1994; 35:1090-7.
9. Rutgeerts P, Goboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338:1401.
10. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341:1437-9.
11. Robert A, Asano T. Resistance of germfree rats to indomethacin induced intestinal lesions. Prostaglandins 1977; 14:333-41.
12. Taurog JD, Richardson JA, Croft JT et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180:2359-64.
13. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
14. Brandwein SL, McCabe RP, Cong Y et al. Spontaneously colitic C3H/ HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 1997; 159:44-52.
15. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterol 1989; 96:795-803.
16. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-90.
17. Palmen MJHJ, Dieleman LA, van der Ende MB et al. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Clin Exp Immunol 1995; 99:226-32.
18. Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 1995; 37:530-5.
19. Gardiner KR, Erwin PJ, Anderson NH, Barr JG, Halliday MI, Rowlands BJ. Colonic bacteria and bacterial translocation in experimental colitis. Br J Surg 1993; 80:512-6.
20. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934-8.
21. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183:2605-16.
22. Wallace JL, Le T, Carter L, Appleyard CB, Beck PL. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharmacol Toxicol Methods 1995; 33:237-9.
23. Kampinga J, Kroese FG, Pol GH et al. RT7-defined alloantigens in rats are part of the leukocyte common antigen family. Scand J Immunol 1990; 31:699-710.
24. Bakker JM, Schmidt ED, Kroes H et al. Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary adrenal axis in the rat. J Neuroimmunol 1995; 63:183-91.
25. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunol 1985; 54:589-99.
26. Damoiseaux JGMC, Döpp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunol 1994; 83:140-7.
27. Dallman MJ, Mason DW, Webb M. The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol 1982; 12:511-8.
28. Woollett GR, Barclay AN, Puklavec M, Williams AF. Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes. Eur J Immunol 1985; 15:168-73.
29. McCall MN, Shotton DM, Barclay AN. Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies. Immunol 1992; 76:310-7.
30. Hume DA, Robinson AP, MacPherson GG, Gordon S. The mononuclear phagocyte system on the mouse defined by immunohistochemical localization of antigen F4/80. J Exp Med 1983; 158:1522.
31. Ledbetter JA, Herzenberg LA. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47:63-90.
32. +) subsets among anti-Ia cytotoxic T cell clones. J Immunol 1984; 132:2775-85.
33. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clones III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-44.
34. Ohara J, Paul WE. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 1985; 315:333-6.
35. Binder M, Dolezal I, Wolff K, Pehamberger H. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in thin malignant melanoma. J Invest Dermatol 1992; 99:180-3.
36. Palmen MJHJ, Dijkstra CD, van der Ende MB, Peña AS, van Rees EP. Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin Exp Immunol 1995; 101:351-6.
37. McDonald SAC, Palmen MJHJ, van Rees EP, MacDonald TT. Characterisation of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunol 1997; 91:73-80.
38. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352:621-4.
39. Noma Y, Sideras P, Naito T et al. Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using a SP6 promoter. Nature 1986; 319:640-6.
40. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995; 155:489-98.
41. Kinashi T, Harada N, Severinson E et al. Cloning of complementary DNA encoding T cell replacing factor and identity with B cell growth factor II. Nature 1986; 324:70-73.
42. Gray PW, Goeddel DV. Cloning and expression of murine interferon cDNA. Proc Natl Acad Sci USA 1983; 80:5842-6.
43. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full length cDNA of mouse cytoskeletal beta-actin mRNA. Nucl Acids Res 1986; 14:2829.
44. MacKay CR. Migration pathways and immunologic memory among T lymphocytes. Sem Immunol 1992; 4:51-58.
45. Jalkanen S. Lymphocyte traffic to mucosa-associated lymphatic tissues. Immunol Res 1991; 10:268-70.
46. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347:669-71.
47. Grimm MC, Pavli P, Doe WF. Local expression and production of monocyte-attracting chemokines in inflammatory bowel disease. Gastroenterol 1995; 108:A827.
48. Teh HS, Phillips RA, Miller RG. Quantitative studies on the precursors of cytotoxic lymphocytes. V. The cellular basis for the cross-reactivity of TNP-specific clones. J Immunol 1978; 121:1711-7.
49. Das KM, Vecchi M, Squillante L, Dasgupta A, Henke M, Clapp N. Mr 40000 human colonic epithelial protein expression in colonic mucosa and presence of circulating anti-Mr 40000 antibodies in cotton top tamarins with spontaneous colitis. Gut 1992; 33:48-54.
50. Savage DC. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 1977; 31:107-33.
51. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995; 3:149-54.
52. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-55.
53. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Gastroenterol 1996; 110:A899.
54. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997; 65:3126-31.